US EditionPublished • loading... • Updated
Frontage Europe Consolidates Milan Lab in Bid to Speed Drug Development
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Frontage Europe Consolidates Milan Lab in Bid to Speed Drug Development
EXTON, PA — Frontage Europe, a wholly owned subsidiary of Frontage Laboratories Inc. (Nasdaq: FHL), has relocated its bioanalytical laboratory to a single, expanded facility near Milan, a move the company says will sharpen efficiency and streamline support for global clinical studies. The newly consolidated laboratory spans approximately 2,500 square meters and brings Frontage Europe’s bioanalytical services under one roof, positioning the opera…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
